Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo E Rodriguez

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Clinical Medicine Insights. Cardiology|July 10, 2019
One-Year Follow-Up Results From the Observational, Multicenter, Prospective, and Controlled Registry: The WALTZ All-Comers StudyAlfredo E Rodriguez, Miguel Larribau, Carlos Fernandez-Pereira, et al.
American Heart Journal|December 17, 2011
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trialGiuseppe Ferrante, Patrizia Presbitero, Elena Corrada, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trialsScot Garg, Giovanna Sarno, Patrick W Serruys, et al.
International Journal of Cardiology|August 26, 2011
Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY)Marco Valgimigli, Gianluca Campo, Stefania Gambetti, et al.
Journal of Clinical Medicine|May 14, 2025
Randomized Clinical Trial Comparing Bare-Metal Stents Plus Colchicine Versus Drug-Eluting Stents for Preventing Adverse Cardiac Outcomes: Three-Year Follow-Up Results of the ORal Colchicine in Argentina (ORCA) TrialAlfredo Matias Rodriguez-Granillo, Juan Mieres, Carlos Fernandez-Pereira, et al.
American Heart Journal|June 23, 2007
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trialMarco Valgimigli, Leonardo Bolognese, Maurizio Anselmi, et al.
Journal of the American College of Cardiology|November 17, 2012
The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trialsMarcus Flather, June-Wha Rhee, Derek B Boothroyd, et al.
Kidney International|June 5, 2016
Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney diseaseDavid M Charytan, Manisha Desai, Maya Mathur, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2013
Quantification of scientific output in cardiovascular medicine: a perspective based on global dataGastón A Rodriguez-Granillo, Alfredo E Rodriguez, Nico Bruining, et al.
Lancet (London, England)|February 27, 2018
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient dataStuart J Head, Milan Milojevic, Joost Daemen, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Clinical Medicine Insights. Cardiology|July 10, 2019
One-Year Follow-Up Results From the Observational, Multicenter, Prospective, and Controlled Registry: The WALTZ All-Comers StudyAlfredo E Rodriguez, Miguel Larribau, Carlos Fernandez-Pereira, et al.
American Heart Journal|December 17, 2011
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trialGiuseppe Ferrante, Patrizia Presbitero, Elena Corrada, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trialsScot Garg, Giovanna Sarno, Patrick W Serruys, et al.
International Journal of Cardiology|August 26, 2011
Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY)Marco Valgimigli, Gianluca Campo, Stefania Gambetti, et al.
Journal of Clinical Medicine|May 14, 2025
Randomized Clinical Trial Comparing Bare-Metal Stents Plus Colchicine Versus Drug-Eluting Stents for Preventing Adverse Cardiac Outcomes: Three-Year Follow-Up Results of the ORal Colchicine in Argentina (ORCA) TrialAlfredo Matias Rodriguez-Granillo, Juan Mieres, Carlos Fernandez-Pereira, et al.
American Heart Journal|June 23, 2007
Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: design and rationale for the MULTI-STRATEGY trialMarco Valgimigli, Leonardo Bolognese, Maurizio Anselmi, et al.
Journal of the American College of Cardiology|November 17, 2012
The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trialsMarcus Flather, June-Wha Rhee, Derek B Boothroyd, et al.
Kidney International|June 5, 2016
Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney diseaseDavid M Charytan, Manisha Desai, Maya Mathur, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2013
Quantification of scientific output in cardiovascular medicine: a perspective based on global dataGastón A Rodriguez-Granillo, Alfredo E Rodriguez, Nico Bruining, et al.
Lancet (London, England)|February 27, 2018
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient dataStuart J Head, Milan Milojevic, Joost Daemen, et al.
Pageof 6